AnnaMed

AnnaMed Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

AnnaMed General Information

Description

Developer of Annamycin drug. The company's Annamycin drug is a clinical stage pharmaceutical drug which provides treatment of acute myeloid leukemia, enabling leukemia patients to recover and lower their pain from acute cancer diseases.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 1973 West Clay Street
  • Houston, TX 77019
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AnnaMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AnnaMed‘s full profile, request access.

Request a free trial